BLyS fusion proteins for targeting BLyS receptor and methods for treatment of B-cell proliferative disorders

Details for Australian Patent Application No. 2006210769 (hide)

Owner Research Development Foundation

Inventors Rosenblum, Michael G.; Cheung, Lawrence; Lyu, Mi-Ae

Agent Pizzeys

Pub. Number AU-A-2006210769

PCT Pub. Number WO2006/083961

Priority 60/649,478 01.02.05 US

Filing date 1 February 2006

Wipo publication date 10 August 2006

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/415 (2006.01) Peptides having more than 20 amino acids - from plants

C07K 14/525 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

26 July 2007 PCT application entered the National Phase

  PCT publication WO2006/083961 Priority application(s): WO2006/083961

25 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210778-Tumor necrosis factor inhibitors

2006210757-Disposable assembly containing a skin piercing element